The Transcriptional Coactivator CAMTA2 Stimulates Cardiac Growth by Opposing Class II Histone Deacetylases  by Song, Kunhua et al.
The Transcriptional Coactivator CAMTA2
Stimulates Cardiac Growth by Opposing
Class II Histone Deacetylases
Kunhua Song,1 Johannes Backs,1 John McAnally,1 Xiaoxia Qi,1 Robert D. Gerard,1,3 James A. Richardson,1,2
Joseph A. Hill,1,3 Rhonda Bassel-Duby,1 and Eric N. Olson1,*
1Department of Molecular Biology
2Department of Pathology
3Department of Internal Medicine
The University of Texas Southwestern Medical Center at Dallas, 6000 Harry Hines Blvd., Dallas, TX 75390, USA
*Contact: eric.olson@utsouthwestern.edu
DOI 10.1016/j.cell.2006.02.048SUMMARY
Postnatal cardiac myocytes respond to diverse
signals by hypertrophic growth and activation
of a fetal gene program. In an effort to discover
regulators of cardiac hypertrophy, we per-
formed a eukaryotic expression screen for acti-
vators of the atrial natriuretic factor (ANF) gene,
a cardiac-specific marker of hypertrophic sig-
naling. We discovered that a family of transcrip-
tional coactivators, called CAMTAs, promotes
cardiomyocyte hypertrophy and activates the
ANF gene, at least in part, by associating with
the cardiac homeodomain protein Nkx2-5. The
transcriptional activity of CAMTAs is governed
by association with class II histone deacety-
lases (HDACs), which negatively regulate car-
diac growth. Mice homozygous for a mutation
in a CAMTA gene are defective in cardiac
growth in response to pressure overload and
neurohumoral signaling, whereas mice lacking
HDAC5, a class II HDAC, are sensitized to the
prohypertrophic actions of CAMTA. These find-
ings reveal a transcriptional regulatory mecha-
nism that modulates cardiac growth and gene
expression by linking hypertrophic signals to
the cardiac genome.
INTRODUCTION
Mammalian cardiac muscle cells respond to mechanical
load and various extracellular stimuli by hypertrophic
growth, characterized by an increase in cell size and pro-
tein synthesis, enhanced assembly of contractile units,
and reactivation of a fetal cardiac gene program (Seidman
and Seidman, 2001; Olson and Schneider, 2003). While
cardiac hypertrophy can have initial salutary effects oncardiac function, when prolonged it is a major predictor
of heart failure and sudden death.
A variety of stress-responsive signaling pathways pro-
mote cardiac hypertrophy, but the mechanisms that link
these pathways to the cardiac genome are only beginning
to be unveiled. Recently, we showed that class II histone
deacetylases (HDACs) act as signal-responsive corepres-
sors of the fetal cardiac gene program and cardiac growth
(Zhang et al., 2002; Chang et al., 2004). The class II
HDACs, HDAC5 and HDAC9, associate with the MEF2
transcription factor and repress its activity (McKinsey
et al., 2000a, 2000b, 2002). Atypical protein kinase C
(PKC) isoforms and the downstream effector kinase pro-
tein kinase D (PKD) regulate cardiac growth by promot-
ing the phosphorylation of class II HDACs, which triggers
their export from the nucleus and consequent activation of
MEF2 target genes (Vega et al., 2004). Consistent with the
proposed roles of class II HDACs as negative regulators
of pathological cardiac growth, knockout mice lacking
HDAC5 or HDAC9 develop massively enlarged hearts in
response to stress (Zhang et al., 2002; Chang et al.,
2004). Whether class II HDACs act solely through MEF2 to
modulate cardiac growth or whether they have additional
transcriptional targets remains an important question.
In an effort to discover regulators of cardiac gene ex-
pression and growth, we devised a eukaryotic expression
screen for cDNAs encoding activators of the atrial natri-
uretic factor (ANF) promoter, a cardiac-specific marker of
hypertrophy and pathological remodeling of the adult
heart. This screen revealed a family of activators of the
ANF promoter, called calmodulin binding transcription
activators (CAMTAs), which are conserved from plants to
humans (Bouche et al., 2002). We show that CAMTAs
are recruited to theANF promoter, at least in part, by asso-
ciation with the cardiac homeodomain protein Nkx2-5 and
function as inducers of cardiac growth. Through gain- and
loss-of-function approaches in vivo and in vitro, we show
that class II HDACs restrain the activity of CAMTAproteins.
Nuclear export of class II HDACs in response to PKC/
PKD signaling releases CAMTAs from HDAC-dependentCell 125, 453–466, May 5, 2006 ª2006 Elsevier Inc. 453
repression with consequent expression of genes involved
in cardiac growth. These findings uncover a role for mam-
malian CAMTA proteins as signal-responsive transcrip-
tional coactivators of cardiac growth and targets for the
antihypertrophic actions of class II HDACs.
RESULTS
Discovery of CAMTA2 in an Expression Screen
for Regulators of the ANF Promoter
We performed a cDNA expression screen by expressing
pools of clones from various cDNA expression libraries
in COS cells and assaying for activation of a luciferase re-
porter controlled by the ANF promoter, which is cardiac
specific and responsive to a variety of signaling pathways
involved in cardiac growth and remodeling (Sprenkle et al.,
1995; Temsah and Nemer, 2005). A total of 2000 cDNA
pools, each containing 100 individual cDNA clones,
was screened, yielding 20 positive pools. Individual
cDNA clones capable of activating ANF-luciferase were
identified by sib-selection. One cDNA, which strongly ac-
tivated the ANF-luciferase reporter, encoded CAMTA2
(Figure 1A), a member of the CAMTA family of transcrip-
tion factors discovered in plants as stress-responsive reg-
ulators of gene expression that respond to calcium/cal-
modulin (Yang and Poovaiah, 2002; Bouche et al., 2002).
TwoCAMTA genes (CAMTA1 andCAMTA2) are predicted
to exist in mice and humans, but their functions have not
been investigated.
The CAMTA2 cDNA isolated in the expression screen
encoded the full-length 1196-amino acidCAMTA2protein.
Members of the CAMTA family share homology in multiple
domains (Figure 1A). A conserved domain of 110 amino
acids, referred to as the CG-1 domain, is located near
the N termini of CAMTA proteins. This domain, which
was first identified in a sequence-specific DNA binding
protein from parsley, has been shown to bind to the DNA
sequence CGCG (da Costa e Silva, 1994). Near the center
of CAMTA proteins is a conserved TIG domain, which has
been implicated in establishing nonspecific DNA contacts
in other transcription factors such as theRel proteinsNFAT
and NF-kB. This domain is followed by ankyrin repeats,
which participate in protein-protein interactions, and a
series of IQ motifs, which bind calmodulin (Bahler and
Rhoads, 2002). CAMTA2 shares high homology with
CAMTA1 and with CAMTA proteins from fruit flies and
plants in each of the above domains,whereas the interven-
ing regions of the proteins are less conserved.
Northern blot analysis revealed a predominantCAMTA2
transcript of 6 kb in adult mouse heart and brain, as well
as minor species in other tissues (Figure 1B). The human
CAMTA2 transcript was detected specifically in heart,
skeletal muscle, and brain (data not shown). Mouse
CAMTA1 transcripts were also detected in brain and heart
(Figure 1B). During embryogenesis, CAMTA2 transcripts
were detected only at a background level in the heart
(data not shown) followed by pronounced upregulation
after birth (Figure 1C). Isolated cardiomyocytes showed454 Cell 125, 453–466, May 5, 2006 ª2006 Elsevier Inc.an enrichment of CAMTA2 expression compared to the
whole heart.
Transcriptional Activation by CAMTA Is Mediated
by Nkx2-5
Weused a series ofANF promoter mutants tomap the cis-
regulatory sequences that conferred responsiveness to
CAMTA2. Deletion mutations from624 bp to97 bp rel-
ative to the transcription initiation site did not impair acti-
vation of the promoter by CAMTA2 in transfected COS
cells (Figure 1D). However, deletion to 74 bp resulted
in a precipitous decline in responsiveness to CAMTA2.
The latter construct retained residual responsiveness
to CAMTA2, which we attribute to the existence of cryptic
CAMTA2 response elements in the reporter plasmid.
CAMTA1 activated the ANF promoter even more strongly
than CAMTA2 (Figure 1E).
The CAMTA-responsive region of the ANF promoter be-
tween 97 and 74 contains binding sites for the cardiac
homeodomain protein Nkx2-5 and the T box factor Tbx5,
both of which have been shown to be important for ANF
transcription (Durocher et al., 1996, 1997; Hiroi et al.,
2001; Sepulveda et al., 1998; Bruneau et al., 2001). The
specific DNA sequence responsible for transcriptional
activation by CAMTA2 was further delineated by point
mutations in this region.Mutations in theNkx2-5-response
element (NKE) abrogated responsiveness to CAMTA2,
whereas mutations in the Tbx binding element (TBE) had
no effect on expression (Figure 1D), suggesting that
CAMTA2 required the NKE to maximally stimulate the
ANF promoter. Consistent with this conclusion, the con-
nexin-40 promoter, which contains two NKEs (Bruneau
et al., 2001), was activated 20-fold by CAMTA2, as was
a reporter containing a single NKE linked to a basal pro-
moter (Figure 1E).
Gel mobility shift assays with GST-CAMTA2 fusion pro-
tein and the CAMTA2-responsive region of the ANF pro-
moter showed no evidence of CAMTA2 DNA binding
(data not shown), suggesting that CAMTA2 might activate
ANF expression via an effect on the expression or tran-
scriptional activity of another factor that bound the NKE.
Indeed, CAMTA2 enhanced the ability of Nkx2-5 to acti-
vate the ANF promoter by 8-fold (Figure 1F). Because
COS cells used for the original expression screen do not
express Nkx2-5, we surmise that NK-type homeodomain
proteins (or other factors) expressed by these cells satisfy
the apparent requirement of CAMTA2 for the NKE in the
ANF promoter.
Association of CAMTA2 with Nkx2-5
on the ANF Promoter
Chromatin immunoprecipitation (ChIP) assays with pri-
mary neonatal rat cardiomyocytes showed that CAMTA2
associated with the NKE in the ANF promoter in native
chromatin (Figure 2A). In transfected COS cells, CAMTA2
was also detected on an exogenous ANF promoter, and
its association with the promoter was enhanced when
coexpressed with Nkx2-5 (Figure 2A), supporting the
Figure 1. Identification of CAMTA2 as an Activator of the ANF Promoter
(A) Schematic diagram of CAMTA proteins frommouse (m), Drosophila melanogaster (Dm), and Arabidopsis thaliana (At). Amino acid identities within
each domain are shown.
(B) Detection of CAMTA transcripts by Northern blot analysis of adult mouse tissues.
(C) Detection of transcripts forCAMTA2 andGAPDH (as a control) by semiquantitative RT-PCR in hearts from rats at E18.5 and postnatal days (P) 1, 4,
and 14.
(D) COS cells were transfected with a CAMTA2 expression plasmid and the indicated ANF-luciferase reporters. Values are expressed as the fold-in-
crease in luciferase expression (± SD) in the presence compared to the absence of CAMTA2. (mutations in the NKE and TBE sites are shown in red.)
(E) COS cells were transfected with aCAMTA2 expression plasmid and the indicated luciferase reporters. Values are expressed as the fold-increase in
luciferase expression (± SD) in the presence compared to the absence of CAMTA. The left panel compares the activities of CAMTA1 and CAMTA2.
(F) COS cells were transfected with ANF-luciferase, the indicated amounts of Nkx2-5 expression plasmid (ng) alone (left side), and 100 ng of CAMTA2
(right side). Values are expressed as the fold-increase in luciferase expression (± SD) with Nkx2-5 and/or CAMTA2 expression plasmids compared to
the reporter alone.conclusion that an endogenous protein in COS cells re-
cruits CAMTA2 to the ANF promoter, allowing its detec-
tion in the expression screen.
As an independent test of the ability of CAMTA2 to as-
sociate with Nkx2-5 on the NKE DNA sequence, we incu-
bated 35S-labeled CAMTA2 protein with a biotinylatedNKE binding site. As shown in Figure 2B, 35S-labeled
CAMTA2 protein associated with the NKE in the presence
of GST-Nkx2-5, but not in the presence of GST alone.
CAMTA2 was distributed in the nucleus and cytoplasm
(Figure 2Ca). In the presence of leptomycin B, an inhibitor
of nuclear export, CAMTA2 became localized exclusivelyCell 125, 453–466, May 5, 2006 ª2006 Elsevier Inc. 455
Figure 2. Interaction of CAMTA and Nkx2-5
(A) Primary neonatal cardiomyocytes (upper panel) were infected with adenovirus encoding FLAG-CAMTA2, ChIP was performed with anti-FLAG an-
tibodyorwithout antibody, andPCRwasperformedwithprimers flanking theNKE in theANFpromoter, as indicated. In the lower panel, COScellswere
transfected with expression vectors encoding FLAG-CAMTA2 or Myc-Nkx2-5, as indicated, and ChIP was performed with the indicated antibodies.
Input DNA was detected using primers for amplification of the NKE site on the ANF promoter. A schematic of the ANF promoter is shown to the right.
(B) A biotinylated DNA probe encompassing the NKE from the ANF promoter was incubated with GST or GST-Nkx2-5 and 35S-methionine-labeled
CAMTA2 protein translated in vitro. Proteins were then captured by binding to streptavidin beads and analyzed by SDS-PAGE.
(C) The subcellular distribution of FLAG-CAMTA2 in transfected COS cells was detected by immunofluorescence. CAMTA2 is distributed in the nu-
cleus and cytoplasm (panel a). In the presence of leptomycin B, CAMTA2 becomes localized to the nucleus (panel b). Similarly, when coexpressed
with Nkx2-5, CAMTA2 colocalized with Nkx2-5 in the nucleus (panels c–e). Deletion of the N-terminal 206 residues (DN206) or C-terminal 80 residues
(DC80) resulted in nuclear or cytoplasmic localization, respectively (panels f and g).
(D) The positions of nuclear export and import sequences in CAMTA2 are shown.to the nucleus (Figure 2Cb), suggesting that the protein cy-
cles between the cytoplasm and the nucleus. When coex-
pressed with Nkx2-5, which is exclusively nuclear, all
CAMTA2 protein became localized to the nucleus, consis-
tent with a possible interaction between the proteins (Fig-
ures 2Cc–2Ce).
Functional Domains of CAMTA2
The transcriptional activity of CAMTA2 was assayed by
fusing portions of the protein to the DNA binding domain
of GAL4. As shown in Figure 3A, CAMTA2 fused to the
GAL4 DNA binding domain activated a GAL4-dependent
luciferase reporter in transfected COS cells; a region be-456 Cell 125, 453–466, May 5, 2006 ª2006 Elsevier Inc.tween amino acids 285 and 468 acted as a transcription
activation domain (TAD). This region was approximately
two orders of magnitude more effective in activating tran-
scription than the full-length protein, suggesting that other
regions may suppress its transcriptional activity, as dis-
cussed later.
To further define the mechanism of action of CAMTA2,
we generated a series of deletion mutants and assayed
their subcellular distribution and ability to activate the
ANF promoter (Figure 3B). Deletion of the CG-1 domain
(mutant DN206) completely abolished the ability of
CAMTA2 to activate the ANF promoter, despite the pres-
ence of the TAD in this mutant. In contrast to the wild-type
Figure 3. Interaction of CAMTA2 and Nkx2-5
(A) Portions of CAMTA2were fused to theGAL4DNA binding domain and assayed for activity with a UAS-luciferase reporter. Values are expressed as
the fold-increase in luciferase expression in the presence of each GAL4-CAMTA2 mutant protein compared to the reporter alone.
(B) Deletion mutants of CAMTA2 were tested for their ability to activate ANF-luciferase in transfected COS cells. Values are expressed as the fold-
increase in luciferase expression in the presence of each CAMTA2 deletion mutant compared to the reporter alone. The presence of the mutant pro-
tein in the nucleus (N) or cytoplasm C, as detected by immunostaining, is shown.
(C) GST-Nkx2-5 was incubated with 35S-methionine-labeled CAMTA2 deletion mutants translated in vitro. Input CAMTA2 proteins are shown in the
top panel. CAMTA2 proteins bound to GST-Nkx2-5 are shown in the middle panel. The lack of binding of CAMTA2 proteins to GST is shown in the
bottom panel.
(D) Summary of binding data for CAMTA deletion mutants.
(E) GST alone or GST fused to portions of Nkx2-5 was incubated with 35S-methionine-labeled CAMTA2 translated in vitro, as indicated.
(F) Summary of binding data for Nkx2-5 deletion mutants.Cell 125, 453–466, May 5, 2006 ª2006 Elsevier Inc. 457
Figure 4. Induction of Cardiac Growth by CAMTA
(A) Primary neonatal rat cardiomyocytes were infected with adenoviruses encoding FLAG-CAMTA2 (right panels) or lacZ (left panels) as a control.
Cells were stained with anti-a-actinin antibody (red) to mark cardiomyocytes, DAPI (blue), and anti-FLAG (green). Ad-CAMTA2 induces profound hy-
pertrophy and sarcomere assembly. Left panels of each set are 10 and right panels are 40 magnification.
(B) Cell size (± SD) in (A) was determined as described in Experimental Procedures.
(C) Numbers of cardiomyocytes and fibroblasts (± SD) in cultures from (A) were determined by counting 20 fields. The adenovirus selectively infects
cardiomyocytes, but not fibroblasts. Hence, the number of fibroblasts remains constant, but the number of cardiomyocytes increases in the presence
of Ad-CAMTA2.
(D) Transgenic mice were generated bearing an a-MHC-CAMTA2 transgene. Hearts from wild-type and transgenic mice (line 1) at 4, 8, and
9 weeks of age are shown at the top. Histological sections are shown in the middle panel and high magnification views of ventricular cardiomyo-
cytes are shown at the bottom. At 9 weeks of age, hypertrophy progresses to dilated cardiomyopathy in a-MHC-CAMTA2 transgenic mice.
Bars = 2 mm.458 Cell 125, 453–466, May 5, 2006 ª2006 Elsevier Inc.
protein, theDN206mutant was localized exclusively to the
nucleus (Figure 2Cf), suggesting that the CG-1 domain
contains a nuclear export sequence (NES) (Figure 2D).
Mutant proteins with larger N-terminal deletions were
also transcriptionally inactive and localized to the nucleus.
Deletion of the C-terminal residues 1116–1196 (mutant
DC80) resulted in complete exclusion of CAMTA2 from
the nucleus (Figure 2Cg), indicative of a nuclear localiza-
tion sequence (NLS) in this region (Figure 2D). As ex-
pected from its cytoplasmic localization, mutant DC80
was unable to activate the ANF promoter (Figure 3B). Be-
cause the NLS was contained in the C-terminal 80 resi-
dues of CAMTA2, we generated internal deletion mutants
that retained this domain. Deletion of the ankyrin-repeat
region (mutant D639–1116) enhanced transcriptional ac-
tivity, suggesting that this region suppresses activity of
the TAD. Deletion mutants that removed the TIG domain
resulted in a total loss of transcriptional activity. We con-
clude that transcriptional activity of CAMTA2 requires
the combined activities of the CG-1, TAD, and TIG do-
mains together with the NLS at the C terminus.
We performed GST pull-down experiments using
a GST-Nkx2-5 fusion protein and mutants of CAMTA2
translated in vitro to map the Nkx2-5 binding domain of
CAMTA2. An interaction of the full-length CAMTA2 protein
with GST-Nkx2-5 was readily detectable in this assay (Fig-
ures 3C and 3D). Deletion of the CG-1 motif resulted in
nearly a complete loss in binding to Nkx2-5. Further dele-
tion of the TIG domain (mutant DN783) abolished the re-
sidual Nkx2-5 binding activity. Deletion mutations from
the C terminus showed that residues 1–207, which en-
compass the CG-1 motif, were sufficient to interact with
Nkx2-5. GST pull-down assays showed that the homeo-
domain of Nkx2-5 was sufficient for association with
CAMTA2 (Figures 3E and 3F).
CAMTA2 Induces Cardiac Hypertrophy
In Vivo and In Vitro
To further investigate the potential function of CAMTA2
as a regulator of cardiac gene expression, we elevated
CAMTA2 expression in primary neonatal rat cardiomyo-
cytes by adenoviral delivery. Ad-CAMTA2 infected cells
displayed a phenotype of hypertrophy and sarcomere
assembly, compared with control cultures infected with
Ad-lacZ (Figures 4A and 4B). Cultures infected with Ad-
CAMTA2 also contained a greater number of cardiomyo-
cytes than control cultures, suggesting that CAMTA2
enhanced myocyte proliferation and/or survival (Figures
4A and 4C).
Next, we generated transgenicmice that overexpressed
CAMTA2 in the heart under control of the a-MHC pro-moter. Two independent stable lines of transgenic mice
and three transgenic founders were viable, but their hearts
were grossly enlarged and showed extensive myocyte hy-
pertrophy (Figures 4D and 4E). In transgenic line 1, which
expressed exogenous CAMTA2 at a level approximately
6-fold higher than endogenous CAMTA2, cardiac hyper-
trophy worsened between 4 and 8 weeks of age. By 9
weeks of age, hypertrophy progressed to dilated cardio-
myopathy and heart failure; and all transgenic animals
died by 12 weeks of age. Transgenic line 2 expressed
CAMTA2 at a level 11.4-fold above normal and displayed
more pronounced hypertrophy (Figure 4E) and high sus-
ceptibility to sudden death. Consistent with the ability of
CAMTA2 to activate the ANF promoter, ANF transcripts
were elevated in the hearts of a-MHC-CAMTA2 transgenic
mice, as were b-type natriuretic peptide (BNP) and b-MHC
transcripts, which are markers of hypertrophy (Figure 4F).
Four transgenic founders expressing theDN206CAMTA2
mutant, which failed to associate with Nkx2-5, showed no
evidence of cardiac hypertrophy, even though the trans-
gene was expressed at levels ranging from 10- to 58-
fold higher than endogenous CAMTA2 (Figure 4E). These
findings support the conclusion that the CG-1 domain of
CAMTA2 is required to promote cardiac growth.
PKC and PKD Signaling Stimulate CAMTA2 Activity
We investigated whether the activity of CAMTA2 might be
enhanced by signaling molecules implicated in cardiac
hypertrophy, including activated calcineurin, activated
MAP kinase MKK6, PKC, and PKD. The transcriptional
activity of CAMTA2 was unaffected by calcineurin or
MKK6. However, as shown in Figure 5A, activated PKC3,
an atypical PKC isoform, and PKD, which act in a hyper-
trophic signaling cascade (Vega et al., 2004), stimulated
the transcriptional activity of CAMTA2. Wild-type PKC3
also enhanced CAMTA2 activity, albeit to a lesser ex-
tent than the constitutively active enzyme, while a domi-
nant-negative form of PKC3 suppressed CAMTA activity
(Figure 5A).
Association of CAMTA2 with Class II HDACs
Signaling by atypical PKCs can induce ANF expression, at
least in part, by stimulating the phosphorylation of class II
HDACs, which results in their translocation from the nu-
cleus to the cytoplasm with consequent derepression of
fetal cardiac genes (Vega et al., 2004). To determine
whether CAMTA2 might be a target for the repressive ef-
fects of class II HDACs on hypertrophic signaling, we
tested whether HDAC5, a class II HDAC, could interfere
with the ability of CAMTA2 to activate the ANF promoter.
Indeed, HDAC5 blocked activation of the ANF promoter(E) Heart weight/body weight ratios (± SD) of wild-type and stable lines a-MHC-CAMTA2 transgenic mice at 4 and 8 weeks of age are shown in the left
panel. Heart weight/body weight ratios of wild-type and F0 transgenic mice harboring a-MHC-CAMTA2 and a-MHC-DN206 transgenic mice (n = 4) at
4 weeks of age are shown in the right panel.
(F) Transcripts representing hypertrophic gene markers (± SD) were detected in hearts of wild-type and a-MHC-CAMTA2 transgenic mice (line 1)
(n = 2) at 8 weeks of age by real-time PCR.Cell 125, 453–466, May 5, 2006 ª2006 Elsevier Inc. 459
Figure 5. Signal-Dependent Regulation of CAMTA2 and Its Association with Class II HDACs
(A) COS cells were transfected with expression plasmids encoding full-length (FL), constitutively active (CA), or dominant-negative (DN) PKC3 or PKD,
and CAMTA2 (100 ng each), as indicated, along with the ANF-luciferase reporter (250 ng). Values are expressed as the fold-increase in luciferase
expression (± SD) compared to the reporter alone.
(B) COS cells were transfected with expression plasmids encoding CAMTA2 (100 ng) or HDAC5 (5 and 25 ng), as indicated, and the ANF-luciferase
reporter (150 ng). Values are expressed as the fold-increase in luciferase expression (± SD) compared to the reporter alone.
(C) Primary neonatal rat cardiomyocytes were infected with adenoviruses encoding FLAG-CAMTA2 (all panels) and GFP-HDAC5 (right panels). Cells
were stained with anti-a-actinin antibody (red) to mark cardiomyocytes, DAPI (blue) to mark nuclei, and GFP (green) to detect HDAC5. Ad-HDAC5
prevents hypertrophy in response to CAMTA2. Magnification = 40.
(D) COS cells were transfected with expression plasmids encoding Myc-HDAC5 and FLAG-CAMTA2 proteins (500 ng each). Input HDAC5 and
CAMTA2 proteins detected by immunoblot (IB) are shown in the top and middle panels, respectively. HDAC5 proteins coimmunoprecipitated (IP)
with CAMTA2 are shown in the bottom panel. Red arrowheads point to CAMTA2 proteins. The full-length protein is expressed at a lower level
than the deletion mutants.
(E) The ability of each CAMTA2 deletion mutant to associate with HDAC5 in (D) is shown. The extent to which each protein is inhibited by HDAC5 is
indicated in the right column. Maximum repression by full-length HDAC5 is set at 100%. NT, not tested because these mutants are inactive.
(F) COS cells were transfected with expression plasmids encoding FLAG-CAMTA2 and Myc-HDAC5 proteins (500 ng each). Input CAMTA2 and
HDAC5 proteins detected by immunoblot (IB) are shown in the top and middle panels, respectively. CAMTA2 proteins coimmunoprecipitated (IP)
with HDAC5 are shown in the bottom panel.
(G) The ability of each HDAC5 deletion mutant to associate with CAMTA2 in (F) is shown. The relative effectiveness of each protein to inhibit CAMTA2
activity is indicated in the right column.
(H) COS cells were transfected with expression plasmids encoding CAMTA2 (300 ng) or HDAC5 (100 ng) either separately or together and a PKD
expression plasmid (600 ng). CAMTA2 (green) and HDAC5 (red) proteins were detected by immunostaining. HDAC5 S/A (panels k–n) contains serine
to alanine mutations at positions 259 and 498 and is refractory to nuclear export by PKD.
(I) Enhanced cardiac hypertrophy of a-MHC-CAMTA2 transgenic (line 1)/HDAC5 mutant mice. Heart weight/body weight measurements (± SD) of
mice of the indicated genotypes were determined at 4 weeks of age. HDAC5/mice show twice the amount of hypertrophy as wild-type transgenics.and prevented hypertrophy in response to CAMTA2 (Fig-
ures 5B and 5C). Similar repression was observed with
HDAC4 (data not shown).460 Cell 125, 453–466, May 5, 2006 ª2006 Elsevier Inc.In coimmunoprecipitation assays, CAMTA2 interacted
avidly with HDAC5, and deletion mutants identified the
ankyrin-repeat domain of CAMTA2 (Figures 5D and 5E)
and the N-terminal regulatory region of HDAC5 (residues
153–360) as the interacting domains (Figures 5F and 5G).
Consistent with the possibility that HDAC5 represses
CAMTA2 through a direct interaction, the CAMTA2 dele-
tionmutantD639–1116 lacking the HDAC5 interaction do-
main displayed higher activity than the full-length CAMTA2
protein (Figure 3B). Deletionmutants of HDAC5 lacking the
HDACdomain (mutants 1–664 and 1–360) but retaining the
CAMTA2 binding domain also repressed the transcrip-
tional activity of CAMTA2 (Figure 5G), in agreement with
prior studies demonstrating that the HDAC domains of
class II HDACs are not required for repression (Zhang
et al., 2002).
Whereas CAMTA2 was distributed in the nucleus and
cytoplasm (Figure 5Ha), when coexpressed with HDAC5,
it became colocalized with HDAC5 in the nucleus (Figures
5He, 5Hg, and 5Hi). In the presence of activated PKD,
HDAC5 translocates from the nucleus to the cytoplasm
(Figures 5Hd, 5Hh, and 5Hj). Under these conditions,
CAMTA2 remained nuclear (Figures 5Hf, 5Hh, and 5Hj).
Moreover, the cytoplasmic pool of CAMTA2 appeared to
enter the nucleus in the presence of PKD, even in the ab-
sence of HDAC5 (Figure 5Hb). CAMTA2 also colocalized
in the nucleus with a mutant form of HDAC5 in which the
signal-responsive serines in the N-terminal regulatory re-
gion were changed to alanines (HDAC5-S/A) (Figures
5Hk and 5Hl). In contrast to wild-type HDAC5, this mutant
remains nuclear in the presence of activated PKD (Figures
5Hm and 5Hn). Thus, hypertrophic signaling leads to dis-
sociation of CAMTA2 from HDAC5 as a consequence of
HDAC5 phosphorylation. The retention of CAMTA2 in
the nucleus, concomitant with the export of HDAC5 to
the cytoplasm, provides a mechanism for signal-depen-
dent activation of CAMTA2-responsive genes.
Antagonism between HDAC5 and CAMTA2 In Vivo
To test whether HDAC5 antagonized the growth-stimula-
tory influence of CAMTA2 on the heart in vivo, we interbred
a-MHC-CAMTA2 transgenic mice (line 1) with mice har-
boring a loss-of-functionmutation inHDAC5. Mice lacking
HDAC5 do not display abnormalities in cardiac size or
function at 1 month of age but are hypersensitive to stress
signaling through the PKD pathway (Chang et al., 2004).
As shown in Figure 5I, the cardiac growth response to
CAMTA2 overexpression was dramatically enhanced in
HDAC5 null mice, providing genetic evidence for the op-
posing roles of CAMTA2 and HDAC5 in the control of car-
diac growth in vivo.
CAMTA2 Knockout Mice Display Diminished
Hypertrophy in Response to Multiple Stimuli
We generated a loss-of-function mutation in the mouse
CAMTA2 gene by homologous recombination to investi-
gate the function ofCAMTA2 in vivo. The targeting strategy
resulted in the deletion of amino acids 5–554, encoded by
exons 3–10 of the gene, and insertion of a lacZ reporter
gene in-frame with amino acid 4 (Figures 6A and 6B).
Mice homozygous for the CAMTA2 null mutation wereviable and fertile and did not display obvious cardiac de-
fects. The absence of CAMTA2 transcripts in mutant mice
was confirmed by RT-PCR (Figure 6C). The lacZ gene
inserted into the CAMTA2 locus was expressed in cardio-
myocytes, as detected by immunostaining (Figure 6D).
Although CAMTA2 mutant mice show no overt cardiac
phenotype, when these mice were subjected to a variety
of hypertrophic stresses, their ability to mount a hypertro-
phic response was severely compromised (Figures 6E–
6J). In response to thoracic aortic banding (TAB), which
promotes hypertrophy by pressure overload, CAMTA2
mutant mice showed only a 22% increase in cardiac
mass compared to a 60% increase in wild-type littermates
(p < 0.006) (Figures 6E and 6F). The induction of fetal car-
diac genes, including ANF, was similarly diminished in
CAMTA2 mutant mice following TAB (Figure 6G). Cardiac
hypertrophy was also suppressed in CAMTA2 mutant
mice following chronic infusion with angiotensin II (Figures
6H and 6I) and the adrenergic agonist isoproterenol (Fig-
ure 6J). In addition, angiotensin II infusion resulted in ven-
tricular fibrosis, which was not observed in CAMTA2
mutant mice (Figure 6I). We conclude that CAMTA2 is
not only sufficient to induce cardiac hypertrophy but is
necessary for a maximal hypertrophic response to diverse
stimuli in vivo.
DISCUSSION
Diverse types of signals induce the heart to undergo hy-
pertrophic growth, which is accompanied by transcrip-
tional reprogramming of cardiac gene expression. Using
the ANF promoter as a sensitive marker of hypertrophic
signaling in a eukaryotic expression screen, we discov-
ered CAMTA2 as a powerful activator of cardiac growth
and gene expression and counterregulator of the
growth-inhibitory activity of class II HDACs.
The CAMTA Family of Transcriptional Coactivators
CAMTA genes have been identified on the basis of nucle-
otide sequence homology in awide rangeof eukaryotes in-
cluding several plant species, nematodes, fruit flies, and
mammals (Bouche et al., 2002), but their functions have
not been examined in any organism. Through mutational
analysis, we identified multiple evolutionarily conserved
functional domains of CAMTA2 (Figure 7A). The CG-1 do-
main is required for association of CAMTA2 with Nkx2-5
and for transcriptional activation of Nkx2-5-dependent
promoters, as well as for induction of cardiac growth.
The TIG domain is essential for stimulation of the ANF pro-
moter but is separable from the TAD, which may reflect
a role in stabilizing the interaction with Nkx2-5. The an-
kyrin-repeat region of CAMTA2 associates with class II
HDACs and negatively modulates the activity of the TAD.
The structural determinants of this interactionmay be sim-
ilar to those thatmediate association of class IIHDACswith
other ankyrin-repeat-containing transcriptional activators
(McKinsey et al., 2006). The IQ motifs near the C terminus
of CAMTA2 can be deletedwithout a loss in transcriptionalCell 125, 453–466, May 5, 2006 ª2006 Elsevier Inc. 461
Figure 6. CAMTA2 Knockout Mice Are Compromised in Their Ability to Mount a Hypertrophic Response
(A) The structure of the mouse CAMTA2 gene is shown. The targeting strategy deleted exons 2–10, removing the CG-1, TAD, and part of the TIG
domain. Positions of primers for PCR and probes for Southern blot are shown.
(B) Genomic DNA digested with Xba I from mice of the indicated genotypes was analyzed by Southern blot.
(C) RNA from heart and brain was analyzed by RT-PCR for the indicated transcripts. Primers for CAMTA2 are shown in (A). Transcripts for GAPDH
were detected as a control.
(D) Histological sections from the heart of a CAMTA2/ mouse and wild-type littermate were stained for expression of lacZ (upper panels). Strong
expression of lacZ was detected in cardiomyocyte nuclei. The middle panels show high-magnification views of cardiomyocytes photographed with
DIC illumination with nuclear lacZ staining in the mutant. The lower panels were stained for lacZ (green) and a-actinin (red) by immunodetection. Rab-
bit anti-b-galactosidase (Ab cam) was used at a dilution of 1:3000.
(E) Wild-type and CAMTA2 null mice were subjected to TAB or sham operation and heart weight/body weight ratios (± SD) were determined after
21 days.
(F) Histological sections of representative hearts from (E) are shown. Hypertrophy in response to TAB is inhibited in CAMTA2 mutant mice.
(G) Transcripts for ANF,BNP, and b-MHCwere detected by real-time PCR in hearts fromwild-type (WT) and CAMTA2 null (KO) mice following TAB (+)
or sham operation (). Three animals in each group were tested. Values are expressed as the fold-increase in transcripts (± SD) compared to these
markers in sham-operated wild-type mice.
(H) Wild-type andCAMTA2 null mice were subjected to chronic infusion of saline or AngII and heart weight/body weight ratios (± SD) were determined
after 14 days.
(I) Histological sections of representative hearts from (H) are shown. The lower panels are stained with Masson Trichrome to detect fibrosis.
(J) Wild-type and CAMTA2 null mice were subjected to chronic infusion of saline or isoproterenol and heart weight/tibia length ratios (± SD) were
determined after 7 days.activity of CAMTA2. The IQmotifs in plant CAMTA proteins
bind calmodulin (Bouche et al., 2002; Yang and Poovaiah,
2002). It will be interesting to further investigate the poten-
tial significance of this domain.462 Cell 125, 453–466, May 5, 2006 ª2006 Elsevier Inc.Regulation of Nkx2-5 Activity by CAMTA2
The following observations support the conclusion that
CAMTA2 acts as a coactivator for Nkx2-5. (1) The Nkx2-5
binding site in the ANF promoter is required for maximal
transcriptional activation by CAMTA2. (2) A single copy of
the Nkx2-5 binding site is sufficient to confer CAMTA re-
sponsiveness to a basal promoter. (3) CAMTA2 synergizes
with Nkx2-5 to activate NKE-dependent promoters. (4)
Nkx2-5 interacts with CAMTA2. (5) CAMTA2 can be de-
tected by chromatin immunoprecipitation on the Nkx2-5
binding region of the ANF promoter within native chroma-
tin or on an exogenous plasmid template. (6) Mutations in
CAMTA2 that disrupt interaction with Nkx2-5 abolish the
ability of CAMTA2 to stimulate Nkx2-5 activity in vitro
and ANF induction in vivo.
Overexpression of CAMTA2 appears to stimulate hy-
pertrophy and proliferation of cardiomyocytes; whether
these two responses are interrelated remains to be deter-
mined. Numerous lines of evidence have implicated
Nkx2-5 in the control of cardiac growth, but the regulatory
mechanisms through which growth signals might impinge
on Nkx2-5 have not been defined. Nkx2-5 expression is
upregulated during hypertrophy (Thompson et al., 1998;
Figure 7. Domains of CAMTA2 and aModel of CAMTA2 Func-
tion in Hypertrophic Signaling
(A) The functional domains of CAMTA2 are shown.
(B) CAMTA2 cycles between the cytoplasm and the nucleus and stim-
ulates the activity of Nkx2-5 and possibly other as yet unidentified tran-
scription factors. CAMTA2 is repressed by association with class II
HDACs. Activation of PKC/PKD signaling leads to phosphorylation of
class II HDACs, which creates docking sites for 14-3-3 proteins and
their nuclear export, releasing CAMTA2 from repression and promot-
ing cardiac growth.Saadane et al., 1999). Overexpression of Nkx2-5 results
in cardiac hyperplasia in Xenopus and zebrafish embryos
(Cleaver et al., 1996; Chen and Fishman, 1996) and hyper-
trophy and heart failure in transgenicmice (Kasahara et al.,
2003). Conversely, expression of an Nkx2-5 dominant-
negative mutant in Xenopus inhibits cardiac growth (Fu
et al., 1998). Our results suggest that induction of cardiac
hypertrophy by CAMTA2 is mediated, at least in part, by
its association with Nkx2-5, although CAMTA2 may also
have additional transcriptional targets. Nkx2-5 also asso-
ciates with other transcription factors, including GATA4,
Tbx5, and serum response factor, with consequent stimu-
lation of Nkx2-5 activity (Chen and Schwartz, 1996; Dur-
ocher et al., 1996, 1997; Hiroi et al., 2001; Sepulveda
et al., 1998; Small and Krieg, 2003).
Mutations in Nkx2-5 result in a spectrum of cardiac ab-
normalities in humans (Schott et al., 1998; Rosenthal and
Harvey, 1999) and mice (Biben et al., 2000; Lyons et al.,
1995; Tanaka et al., 1999), which have been attributed to
dysregulation of cardiac growth and aberrant regulation
of cell lineages contributing to the cardiac conduction sys-
tem (Pashmforoush et al., 2004). CAMTA2 does not show
appreciable expression in the heart until after birth,
whereas CAMTA1 is strongly expressed in the embryonic
heart (data not shown). Perhaps CAMTA1 modulates the
developmental functions of Nkx2-5.
Signaling to CAMTA via Class II HDACs
PKC signaling is a powerful inducer of cardiac growth
(Dorn and Force, 2005). We have shown that atypical
PKCs activate PKD, which directly phosphorylates class
II HDACs, resulting in their export from the nucleus to the
cytoplasm and activation of fetal cardiac gene expression
(Vega et al., 2004). Phosphorylation and nuclear export of
class II HDACs are accompanied by the derepression of
MEF2, a transcription factor implicated in fetal cardiac
gene expression and myocardial growth (McKinsey et al.,
2002). However, MEF2 does not regulate all of the genes
that are induced during hypertrophy, suggesting the in-
volvement of additional transcriptional regulators.
The results of this study identify CAMTA2 as an indepen-
dent target of class II HDACs (Figure 7B). In the absence of
hypertrophic signaling, the nuclear fraction of CAMTA2can
associate with HDAC5, resulting in repression of CAMTA2
transcriptional activity. Signaling by PKC and PKD can
stimulate CAMTA activity by promoting the translocation
of class II HDACs to the cytoplasm, relieving their repres-
sive influence on CAMTA. Consistent with this model, a
signal-resistant HDAC5 mutant lacking the phosphoryla-
tion sites required for nuclear export blocks CAMTA activ-
ity even in the face of PKC signaling (data not shown). No-
tably, HDAC5 associates with CAMTA2 andMEF2 through
different regions of its N-terminal regulatory domain,
potentially allowing it to independently repress both tran-
scription factors in a signal-dependent manner.
Multiple G protein-coupled receptors drive cardiac
growth by signaling through PKD to class II HDACs (Vega
et al., 2004; Harrison et al., 2006). The finding that geneticCell 125, 453–466, May 5, 2006 ª2006 Elsevier Inc. 463
deletion of CAMTA2 desensitizes the heart to signaling by
G protein-coupled receptor agonists, as well as pressure
overload, whereas genetic deletion of HDAC5 sensitizes
the heart to the growth-stimulatory activity of CAMTA2,
suggests that CAMTA2 is a key downstream effector of
hypertrophic signaling in vivo. The residual hypertrophic
response of CAMTA2 null mice is likely to reflect the in-
volvement of parallel, partially redundant, signaling mech-
anisms possibly involving CAMTA1, as well as other effec-
tors. It is noteworthy that the inability ofCAMTA2 null mice
to mount a full hypertrophic response does not result in
cardiac demise, indicating that hypertrophy is not a
necessary response to cardiac stress.
Other Potential Functions of CAMTA Proteins
The association of transcription factors with coactivators
(and corepressors) allows for signal-dependent regulation
of gene expression and expands the regulatory potential
of cis-acting DNA sequences as a consequence of combi-
natorial protein-protein interactions. While many, perhaps
even most, cardiac transcription factors have been identi-
fied, the transcriptional coactivators that regulate cardiac
growth or development are only beginning to be identified.
CAMTA proteins join a growing list of transcriptional coac-
tivators involved in the control of cardiac gene regulation
during development and disease, including myocardin,
EYA4 and TAZ (Wang et al., 2001; Schonberger et al.,
2005; Murakami et al., 2005).
We speculate that CAMTA proteins may have transcrip-
tional partners in addition to Nkx2-5 in cardiac myocytes,
as well as other tissues (such as brain) where Nkx2-5 is not
expressed. It is intriguing that CAMTA1 and 2 are ex-
pressed at the highest levels in heart and brain, which de-
pend on calcium signaling for excitability and gene ex-
pression. Perhaps calcium-dependent HDAC signaling
pathways modulate CAMTA activity in neurons. In the
future, it will be interesting to identify other potential part-
ners of CAMTA proteins, to determine the extent of redun-
dancy and uniqueness of the functions of CAMTA1 and 2,
and to investigate their potential involvement in human
disease.
EXPERIMENTAL PROCEDURES
Expression cDNA Library and Expression Screen
The expression screen assay was performed using the ANF638-luc re-
porter (Sprenkle et al., 1995). cDNA expression libraries from human
brain (Promega) and fetal heart (Invitrogen) were separated into pools
containing 50–100 clones each. Pooled plasmid DNA was purified
using PerfectPrep Plasmid 96 Vac Direct Bind kit (Eppendorf). The ini-
tial CAMTA2 cDNA clone was isolated from the human brain library.
COS-1 cells plated in 24-well plates in DMEM with 10% FBS were
transfected with 190 ng of pooled plasmid DNA from each expression
library, 100 ng ofANF638-luc reporter (Sprenkle et al., 1995), and 10 ng
of internal control pCMV-LacZ using FuGENE 6 (Roche). After 40 hr of
transfection, the cells were harvested in 200 ml of passive lysis buffer
(Promega), and cell lysates were used for luciferase and b-galactosi-
dase assays. E. coli were transformed with positive plasmid pools
and 12 colonies from each positive pool were picked and combined
as a subpool. Plasmids were purified from 16 subpools and used to464 Cell 125, 453–466, May 5, 2006 ª2006 Elsevier Inc.transfect COS-1 cells in the presence of ANF638-luc reporter and
pCMV-lacZ as described above. Plasmid DNA from single colonies
was prepared and sequenced.
Plasmids and Transfection Assays
Reporter plasmids containing regions of the rat ANF promoter were
generated by PCR. Mutation of the NKE site in the rat ANF promoter
was performed using the QuickChange kit (Stratagene). CAMTA1
and 2, FLAG- or c-myc-tagged cDNAs were ligated into pcDNA3.1 (In-
vitrogen). Transfections were performed using FuGENE 6 (Roche). Ten
nanograms of a lacZ reporter controlled by the Rous sarcoma virus
promoter and enhancer was included as an internal control in all trans-
fection assays.
Isolation of Neonatal Rat Cardiomyocytes
and Adenovirus Infection
Neonatal rat cardiac myocytes were isolated from 1- to 3-day-old
Sprague-Dawley rats. Eighteen to thirty-six hours after plating, cardio-
myocytes were infected with recombinant adenovirus for 2.5 hr and
subsequently cultured in serum-free medium for 48 hr to examine cel-
lular hypertrophy or for 120 hr to count myocytes.
Chromatin Immunoprecipitation Assay
COS-1 cells (2 105) were transfected with an ANF reporter plasmid
alone (200 ng) or with myc-Nkx2-5 (400 ng) and Flag-CAMTA2 (400 ng)
expression plasmids. Twenty-four hours following transfection, chro-
matin immunoprecipitation (ChIP) assays were performed using the
ChIP assay kit (Upstate Biotech). Cardiomyocytes (5  106) were in-
fected with recombinant adenovirus expressing Flag-CAMTA2 at
a MOI of 50 and the ChIP assay was performed.
Glutathione S-Transferase Pull-Down Assays
MouseNkx2-5 cDNAand aDNA fragment encoding theNkx2-5 homeo-
domain were subcloned into the pGEX-KG vector (Amersham Biosci-
ences). The plasmid containing the amino-terminal deletion of Nkx2-5
fused to GST and GST-Nkx2-5-DN were gifts from Dr. Issei Komuro
(Hiroi et al., 2001). Pull-down assays were performed as previously de-
scribed (Lu et al., 2000).
Detection of a Ternary Complex of CAMTA2, Nkx2-5, and NKE
The sequence of the biotinylated oligonucleotide corresponded
to a high-affinity NKE site in the ANF promoter: 50-TCACACCTT
TGAAGTGGGGGCCTCTTGAGGCAAAT-30. Ten microliters of in vitro
[35S]-labeled CAMTA2 protein, generated using the TNT Coupled Re-
ticulocyte Lysate System (Promega), was incubated with 0.2 ug of GST
or GST-Nkx2-5 fusion protein, 0.1 pM of biotinylated NKE, 10 mg of
poly dI/dC (Sigma), and 10 ml of streptavidin beads (Amersham Biosci-
ences) in 200 ml of DNA binding buffer (10 mM Hepes pH 7.6, 1 mM
EDTA pH 8.0, 100 mM KCl, 1 mM DTT, 0.3 mg/ml BSA, and 5% gly-
cerol) for 20 min at room temperature. The beads were washed three
times using 500 ml of the above binding buffer, the bound proteins
were resolved by SDS-PAGE, and [35S]-CAMTA2 was detected by
autoradiography.
RNA Analyses, Immunoprecipitation, and Western Blot Analysis
RNA analyses, immunoprecipitation, and Western blot analysis were
performed as previously described (Lu et al., 2000). Total RNA was
isolated from mouse hearts using TRIzol reagent (Invitrogen). RT-PCR
was performed using 1 mg of RNA as a template with random hexamer
primers to generate cDNA. Sequences of PCR primers are available
upon request. Human or mouse multiple tissue Northern blots (Clon-
tech) were hybridized with a 32P-labeled probe containing CAMTA1
and CAMTA2 cDNA sequence.
Immunoprecipitations were performed by incubating 300 ml of lysate
supernatant with 15 ml anti-FLAG-agarose beads (Sigma) at 4ºC for
1.5 hr. The beads were washed three times with lysis buffer and boiled
in SDS sample buffer. The immunoprecipitated proteins were resolved
by SDS-PAGE and analyzed byWestern blot using rabbit anti-myc an-
tibody (Santa Cruz) at a dilution of 1:1,000 and anti-rabbit IgG conju-
gated to horseradish peroxidase at a dilution of 1:10000 with detection
by Luminol Reagent (Santa Cruz).
Generation of Transgenic Mice
A cDNA encoding mouse FLAG-tagged CAMTA2 was cloned into an
expression plasmid containing the a-MHC promoter and human GH
(hGH) poly(A)+ signal (Subramaniam et al., 1991), and transgenic
mice were generated by standard techniques. Genotyping was per-
formed by PCR using genomic DNA. Cardiac expression of CAMTA2
in transgenic mice was evaluated by real-time PCR or immunohisto-
chemistry with anti-FLAG antibody (Sigma) to detect FLAG-tagged
CAMTA2.
Generation of CAMTA2 Knockout Mice
The CAMTA2 targeting construct was built using the pN-Z-TK2 vector,
which contains a nuclear LacZ (nLacZ) cassette and a neomycin-resis-
tance gene (kindly provided by R. Palmiter). The 1.8 kb 50 arm and 5.7
kb 30 armwere amplified using PCR and confirmed by sequencing. The
nLacZ and neomycin cassette were fused in-frame to exon 3 following
the first 4 amino acids of CAMTA2, placing the LacZ reporter gene un-
der the control of the endogenous CAMTA2 promoter. The targeting
construct was linearized and electroporated into 129 SvEv-derived
ES cells. Using Southern blot analysis with 50 and 30 probes, two
CAMTA2 targeted ES clones were identified and used for blastocyst
injection. The resulting chimeric mice were bred to C57BL/6 to obtain
germline transmission of the mutant allele.
Thoracic Aortic Banding, Infusion of Angiotensin II
and Isoproterenol
Six-week-old mice underwent either a sham operation or were sub-
jected to pressure overload induced by TAB as previously described
(Hill et al., 2000). Cardiac hypertrophic agonists angiotensin II (3 mg/
kg/d) (American Peptide) or saline were administered using minios-
motic pumps (model 2002, Alzet) subcutaneously implanted dorsally
in 8-week-old male mice. Isoproterenol (Sigma) (8.7 mg/kg/d) or saline
were administered to 16-week-old mice using osmotic minipumps
(model 2001, Alzet). Mice were sacrificed 14 days after angiotensin II
administration or 7 days following isoproterenol infusion. Cardiac hy-
pertrophy was evaluated by measuring heart weight, body weight,
and tibia length.
Histology and Immunohistochemistry
Histology and immunohistochemistry were performed by standard
techniques. Immunostaining of frozen tissue sections for b-galactosi-
dase expression was performed as described at the website of the
Wellcome Trust Sanger Institute (http://www.sanger.ac.uk). Cell size
was measured using NIH Scion Image software.
Animal Care
All animal procedures were previously approved by the Institutional
Animal Care and Use Committee at UT Southwestern Medical Center.
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